Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19

NCT04468893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-10-13

No results posted yet for this study

Summary

This study evaluates the effectiveness of a Positive Psychology intervention, that is focused on increasing the positive emotions and strengths of human beings. It is compared to the effectiveness of an online treatment with the change of the same participants before and after receiving the treatment accompanied by a chat support service vs. the treatment solely. The changes are being assessed through worldwide validated measures such as psychometrics.

Conditions

Interventions

BEHAVIORAL

Online Intervention Mental Health COVID-19

The Online Intervention Mental Health COVID-19 aims to provide to the target population a self-applied intervention based primarily on Positive Psychology, aimed at the recognition and development of strengths and virtues from the well-being approach. In addition, it is supported by elements of Cognitive Behavioral Therapy such as the components of emotion and the Antecedent-Response-Consequence (ARC) model of emotions. Elements of Behavioral Activation Therapy are also included, such as the importance of physical exercise and the relationship between physical anxiety and its effects on anxiety and depression. The intervention is made up of 15 modules that are adapted to the symptoms that the population may suffer from the global contingency caused by the COVID-19 pandemic. In addition to the Positive Psychology modules, a module with psychoeducation on grief and loss was added.

Sponsors & Collaborators

  • Universidad Nacional Autonoma de Mexico

    collaborator OTHER
  • Universidad Autonoma de Ciudad Juarez

    collaborator OTHER
  • Universidad Internacional de Valencia

    lead OTHER

Principal Investigators

  • Anabel de la Rosa Gómez, PhD · Universidad Nacional Autonoma de Mexico

  • Paulina Arenas Landgrave, PhD · Universidad Nacional Autonoma de Mexico

  • Jasshel Teresa Salinas-Saldivar, MD · Universidad Autónoma de Ciudad Juárez

  • Flor Rocio Ramirez-Martinez, PhD · Universidad Autónoma de Ciudad Juárez

  • Sofía Cristina Martínez Luna, MD · Universidad Nacional Autonoma de Mexico

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-20
Primary Completion
2021-07-31
Completion
2021-07-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04468893 on ClinicalTrials.gov